Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421)

L. A. Marlow, J. D'Innocenzi, Y. Zhang, S. D. Rohl, S. J. Cooper, T. Sebo, C. Grant, B. McIver, J. L. Kasperbauer, J. T. Wadsworth, J. D. Casler, P. W. Kennedy, W. E. Highsmith, O. Clark, D. Milosevic, B. Netzel, K. Cradic, S. Arora, C. Beaudry, S. K. GrebeM. L. Silverberg, D. O. Azorsa, R. C. Smallridge, J. A. Copland

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number11
DOIs
StatePublished - Nov 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Marlow, L. A., D'Innocenzi, J., Zhang, Y., Rohl, S. D., Cooper, S. J., Sebo, T., Grant, C., McIver, B., Kasperbauer, J. L., Wadsworth, J. T., Casler, J. D., Kennedy, P. W., Highsmith, W. E., Clark, O., Milosevic, D., Netzel, B., Cradic, K., Arora, S., Beaudry, C., ... Copland, J. A. (2013). Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421). Journal of Clinical Endocrinology and Metabolism, 98(11). https://doi.org/10.1210/jc.2013-3548